Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...
Daisy Edgar-Jones said in an interview with Elle Magazine that she is quite fortunate her A-list male co-stars have never ...
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, ...
President Donald Trump announced Friday that Boeing will build the Air Force’s future fighter jets, which the Pentagon says ...
Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...
BEIJING (AP) — U.S. Sen. Steve Daines, a strong supporter of President Donald Trump, has met a senior Chinese diplomat in ...
Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four ...
US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a first-in-class ...